Zeshaan Rasheed

Publications

• Biological and Clinical Relevance of Stem Cells in Pancreatic Adenocarcinoma
  Journal of Gastroenterology and Hepatology. Mar, 2012  |   Pubmed ID: 22320910
• Cyclin-dependent Kinase Inhibitor Dinaciclib (SCH727965) Inhibits Pancreatic Cancer Growth and Progression in Murine Xenograft Models
  Cancer Biology & Therapy. Oct, 2011  |   Pubmed ID: 21768779
• Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem Cells
  Stem Cells (Dayton, Ohio). Jun, 2011  |   Pubmed ID: 21509907
• Tumor-initiating Cells Are Rare in Many Human Tumors
  Cell Stem Cell. Sep, 2010  |   Pubmed ID: 20804964
• A Combination of DR5 Agonistic Monoclonal Antibody with Gemcitabine Targets Pancreatic Cancer Stem Cells and Results in Long-term Disease Control in Human Pancreatic Cancer Model
  Molecular Cancer Therapeutics. Sep, 2010  |   Pubmed ID: 20660600
• Prognostic Significance of Tumorigenic Cells with Mesenchymal Features in Pancreatic Adenocarcinoma
  Journal of the National Cancer Institute. Mar, 2010  |   Pubmed ID: 20164446
• A Direct Pancreatic Cancer Xenograft Model As a Platform for Cancer Stem Cell Therapeutic Development
  Molecular Cancer Therapeutics. Feb, 2009  |   Pubmed ID: 19174553
• Topors Functions As an E3 Ubiquitin Ligase with Specific E2 Enzymes and Ubiquitinates P53
  The Journal of Biological Chemistry. Aug, 2004  |   Pubmed ID: 15247280
• The Topoisomerase I- and P53-binding Protein Topors is Differentially Expressed in Normal and Malignant Human Tissues and May Function As a Tumor Suppressor
  Oncogene. Jul, 2004  |   Pubmed ID: 15107820
• Mechanisms of Resistance to Topoisomerase I-targeting Drugs
  Oncogene. Oct, 2003  |   Pubmed ID: 14576839
• The Topoisomerase I-binding RING Protein, Topors, is Associated with Promyelocytic Leukemia Nuclear Bodies
  Experimental Cell Research. Jul, 2002  |   Pubmed ID: 12083797